These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35154707)

  • 1. Patient with prostatic adenocarcinoma with plasmacytoid features and an aberrant immunohistochemical phenotype diagnosed by biopsy and a mini-review of plasmacytoid features in the genitourinary system: A case report.
    Zacharouli K; Vageli DP; Koukoulis GK; Ioannou M
    Mol Clin Oncol; 2022 Mar; 16(3):67. PubMed ID: 35154707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmacytoid acinar adenocarcinoma of the prostate: a newly described variant of prostate cancer.
    Al-Hussain T; Haffner MC; Altaweel WM; Epstein JI
    Hum Pathol; 2019 Dec; 94():86-91. PubMed ID: 31698007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear cell urothelial carcinoma of the urinary bladder: a case report and review of the literature.
    Knez VM; Barrow W; Lucia MS; Wilson S; La Rosa FG
    J Med Case Rep; 2014 Aug; 8():275. PubMed ID: 25124389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
    Gordetsky J; Epstein JI
    Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
    Osunkoya AO; Hansel DE; Sun X; Netto GJ; Epstein JI
    Am J Surg Pathol; 2008 Mar; 32(3):461-7. PubMed ID: 18300803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis.
    Baydar DE; Kulac I; Gurel B; De Marzo A
    Int J Surg Pathol; 2011 Feb; 19(1):131-6. PubMed ID: 20719821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
    Genega EM; Hutchinson B; Reuter VE; Gaudin PB
    Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
    Epstein JI; Egevad L; Humphrey PA; Montironi R;
    Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
    Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
    J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The eternal enigma in prostatic biopsy access route.
    Fabiani A; Principi E; Filosa A; Servi L
    Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases.
    Fritsche HM; Burger M; Denzinger S; Legal W; Goebell PJ; Hartmann A
    J Urol; 2008 Nov; 180(5):1923-7. PubMed ID: 18801525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
    Ormsby AH; Haskell R; Jones D; Goldblum JR
    Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucinous adenocarcinoma of the prostate. A case report and analysis of the literature].
    Watarai Y; Demura T; Togashi M; Ohashi N; Chikaraishi T; Hirano T; Fukazawa Y
    Nihon Hinyokika Gakkai Zasshi; 1994 Aug; 85(8):1276-9. PubMed ID: 7523749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer detection yield in repeated biopsy is independent of the diagnosis of earlier biopsies.
    Grepl M; Student V; Furst T; Furstova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Dec; 153(4):297-302. PubMed ID: 20208971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.